Latest S-1 registration statements

Blue Star Foods Corp. has filed an amendment to its registration statement for the potential offer and resale of up to 19,876,735 shares of its common stock by selling stockholders.

Azitra, Inc. is planning to raise capital through an offering of common stock and pre-funded warrants, according to a recent S-1 filing.

BIOLASE, Inc. announces a proposed best efforts offering of units and pre-funded units to raise capital for working capital and general corporate purposes.

Perfect Moment Ltd. files an amendment to its S-1 registration statement for an IPO and extends the maturity date of its convertible promissory notes.

AgEagle Aerial Systems has filed a registration statement for the resale of up to 16,319,165 shares of common stock by selling shareholders, issuable upon the exercise of warrants.

Helix Acquisition Corp. II, a blank check company affiliated with Cormorant Asset Management, aims to raise $100 million in an initial public offering to pursue a business combination within the healthcare sector.

Envoy Medical seeks to register the issuance and resale of Class A Common Stock and warrants, potentially raising $46.7 million.

High Roller Technologies, an online gaming operator, is seeking to raise $13.5 million through an initial public offering and list its common stock on the NYSE American under the ticker symbol HRLR.

Aditxt, Inc. has filed a registration statement for the resale of up to 3,785,569 shares of its common stock by selling stockholders, derived from pre-funded and common warrants.

EzFill Holdings plans a public offering to fund acquisitions and growth, including the potential acquisition of Next Charging, a renewable energy company.

ECD Automotive Design intends to offer for resale shares of its common stock and warrants, as well as shares underlying those warrants, according to a recent SEC filing.

TransCode Therapeutics is offering shares and warrants to fund its oncology platform, including its lead candidate TTX-MC138, while facing Nasdaq compliance challenges.

Nuwellis, Inc. plans to offer units and pre-funded units to raise capital for working capital and general corporate purposes.

Accelerate Diagnostics is offering 4,500,000 units and pre-funded units, each including common stock or pre-funded warrants and warrants, to raise capital for its Wave program and general corporate purposes.

CG Oncology, a late-stage biopharmaceutical company, is set to launch its IPO on the Nasdaq, aiming to raise capital for its bladder cancer therapeutic, cretostimogene.

Therapeutic Solutions International (TSOI) has filed a prospectus for the resale of up to 300 million shares of its common stock by a selling shareholder, with the company potentially receiving up to $9.2 million from initial sales to GHS Investments, LLC.

Imunon, Inc. is launching a public offering to sell shares of common stock and warrants, aiming to raise capital for general corporate purposes.

Cemtrex, Inc. announces a proposed public offering of common stock and warrants to raise capital for operations, marketing, and potential acquisitions.

BrightSpring Health Services outlines its employee stock unit grant program following its upcoming IPO, aiming to incentivize and retain key personnel.

TransCode Therapeutics implements a 1-for-40 reverse stock split and launches a public offering of common stock and warrants to advance its oncology-focused RNA therapeutic platform.

Aeries Technology seeks to register the issuance of shares upon exchange and warrant exercise, along with the resale of existing shares and warrants by selling securityholders.

SeqLL Inc. outlines the terms of Series A and B warrants and its merger with Lyneer Investments in a recent SEC filing.

Ensysce Biosciences is seeking to raise capital through a public offering of common stock, pre-funded warrants, and common stock purchase warrants.

Reliance Global Group is registering for resale up to 4,210,528 shares of its common stock issuable upon the exercise of Series G warrants held by a selling securityholder.

Biofrontera Inc. announces a proposed public offering of common stock and warrants to fuel working capital and growth initiatives.

GraniteShares Platinum Trust has filed a registration statement to offer additional shares representing fractional undivided beneficial interest in the Trust's net assets, aiming to reflect the performance of platinum prices.

Chromocell Therapeutics amends a senior secured convertible note and files a resale prospectus for existing stockholders in connection with its IPO.

Kyverna Therapeutics, a clinical-stage biopharmaceutical company, has filed for an initial public offering to further develop its cell therapies for autoimmune diseases, including its lead candidate KYV-101.

Kisses From Italy Inc. is filing an amendment to its registration statement to allow selling stockholders to resell up to 77,081,584 shares of common stock.

GMTech Inc. has filed an amendment to its registration statement for a proposed public offering of 7,000,000 shares of common stock at $0.02 per share.